Ephedrine Export Market Intelligence: India's 59 Suppliers Shipping to 56 Countries — TransData Nexus 2026

Q: Who are the top ephedrine exporters from India?

The top ephedrine exporters from India are: 1. MANKIND PHARMA LIMITED — $4.6M (20.2% market share); 2. SUN PHARMACEUTICAL INDUSTRIES LIMITED — $3.3M (14.8% market share); 3. LABORATE PHARMACEUTICALS INDIA LTD — $3.2M (14.4% market share); 4. GRANULES INDIA LIMITED — $2.1M (9.4% market share); 5. DR REDDYS LABORATORIES LIMITED — $2.0M (9.1% market share). Together they account for 67.8% of India's total ephedrine export value.

Q: What is the total export value of ephedrine from India?

The total export value of ephedrine from India is $22.5M USD, recorded across 389 shipment transactions from 59 active exporters to 56 destination countries. The average shipment value is $57.9K.

Q: Which countries import ephedrine from India?

India exports ephedrine to 56 countries worldwide. The top importing countries are: UNITED STATES (60.5% share, $13.6M), NIGERIA (20.6% share, $4.6M), CANADA (9.8% share, $2.2M), KENYA (1.2% share, $260.7K), ALGERIA (1.0% share, $231.2K). These five markets account for 93.1% of total export value.

Q: What is the HS code for ephedrine exports from India?

The primary HS code for ephedrine exports from India is 30049099. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) for tracking and reporting pharmaceutical trade flows.

Q: What is the average price of ephedrine exports from India?

The average unit price for ephedrine exports from India is $11.28 USD per unit, with prices ranging from $0.01 to $135.06 depending on formulation, packaging, and order volume. The total market is valued at $22.5M across 389 shipments.

Q: Which ports handle ephedrine exports from India?

The primary ports for ephedrine exports from India are DELHI AIR (14.7% of shipments), DELHI AIR CARGO ACC (INDEL4) (9.5% of shipments), SAHAR AIR CARGO ACC (INBOM4) (7.2% of shipments), PATLI ICD (7.2% of shipments), SAHAR AIR (6.7% of shipments). These ports have dedicated pharmaceutical cargo infrastructure ensuring cold-chain and regulatory compliance during transit.

Q: Why is India a leading exporter of ephedrine?

India is one of the world's leading exporters of ephedrine due to its large base of 59 WHO-GMP and US FDA approved manufacturers, significantly lower production costs compared to Western markets, well-established API (Active Pharmaceutical Ingredient) supply chains, and strong government support for pharmaceutical exports through the Pharmaceuticals Export Promotion Council (Pharmexcil). India exports ephedrine to 56 countries, demonstrating 29% global market coverage.

Q: What certifications do Indian ephedrine exporters need?

Indian ephedrine exporters typically require WHO-GMP (Good Manufacturing Practice) certification for most regulated markets, US FDA approval for exports to the United States, EU GMP certification for European markets, and country-specific regulatory approvals for markets in Africa, Asia, and Latin America. Additional certifications may include ISO 9001, Schedule M compliance under Indian drug laws, and Free Sale Certificates issued by the Central Drugs Standard Control Organization (CDSCO).

Q: How many buyers import ephedrine from India?

There are 116 registered buyers importing ephedrine from India, spread across 56 countries. The repeat buyer rate is 51.7%, indicating strong long-term trade relationships and consistent product quality.

Q: What is the market share of the top ephedrine supplier from India?

MANKIND PHARMA LIMITED is the leading ephedrine exporter from India with a market share of 20.2% and total export value of $4.6M across 27 shipments. The top 5 suppliers together control 67.8% of total export value.

Suresh Sormare

Ephedrine

India Pharmaceutical Trade Intelligence

$22.5M59 Suppliers56 CountriesHS 30049099

ExportsIndia → UNITED STATES60.5%India → NIGERIA20.6%

#1 Supplier: MANKIND PHARMA

Ephedrine Export Analysis | India Pharmaceutical Trade Intelligence | TransData Nexus

How India Exports Ephedrine to the World

Between 2022 and 2026, India exported $22.5M worth of ephedrine across 389 verified shipments to 56 countries — covering 29% of world markets in the Respiratory & OTC segment. The largest destination is UNITED STATES (60.5%). MANKIND PHARMA LIMITED leads with a 20.2% share. All figures are drawn from Indian Customs (DGFT) shipping bill records spanning four years of trade activity.

Source: Indian Customs (DGFT)·Published March 2026·Updated March 2026·

Ephedrine export data from India — top exporters, importing countries, pricing and trade statistics compiled by TransData Nexus — Ephedrine export data snapshot — $22.5M · 59 exporters · 56 countriesTransData Nexus · Indian Customs Data

Top Ephedrine Exporters from India

59 active exporters · Ranked by export value

View all 59 →

Top Ephedrine Exporters from India — Ranked by Export Value
#	Supplier Name	Export Value (USD)	Shipments	Countries	Market Share
1	MANKIND PHARMA LIMITED	$4.6M	27	1	20.2%
2	SUN PHARMACEUTICAL INDUSTRIES LIMITED

Top Countries Importing Ephedrine from India

56 destination markets · Ranked by import value

All 56 countries →

Top Countries Importing Ephedrine from India — Ranked by Import Value
#	Country	Import Value (USD)	Market Share
1	UNITED STATES	$13.6M	60.5%
2	NIGERIA	$4.6M	20.6%
3	CANADA	$2.2M	9.8%
4	KENYA	$260.7K	1.2%
5	ALGERIA	$231.2K	1.0%
6	UNITED KINGDOM	$194.5K	0.9%
7	MALAYSIA	$143.2K	0.6%
8	SENEGAL	$114.2K	0.5%
9	PERU	$97.3K	0.4%
10	SUDAN	$92.5K	0.4%

UNITED STATES is India's largest ephedrine export destination, absorbing 60.5% of total exports worth $13.6M. The top 5 importing countries — UNITED STATES, NIGERIA, CANADA, KENYA, ALGERIA — together account for 93.1% of India's total ephedrine export value. The remaining 51 destination countries collectively receive the other 6.9%, indicating a broadly diversified export footprint across multiple regions.

Regulatory Landscape — Ephedrine

Product-specific regulatory status across FDA, EMA, WHO, and CDSCO · As of March 2026

1FDA & US Market Regulatory Status

In the United States, ephedrine is regulated by the Food and Drug Administration (FDA) and is subject to stringent controls due to its potential for misuse. The FDA has issued Import Alert 54-13, titled "Detention Without Physical Examination of Dietary Supplements And Bulk Dietary Ingredients Containing Ephedrine Alkaloids From All Countries," effective since February 21, 2025. This alert allows for the detention of such products without physical examination, underscoring the FDA's commitment to preventing the entry of potentially harmful substances into the U.S. market.

Given the regulatory landscape, Indian exporters aiming to penetrate the U.S. market must navigate these stringent controls. The presence of 59 active Indian exporters and a repeat buyer rate of 51.7% indicates a competitive market, necessitating strict adherence to FDA regulations to ensure market access and sustainability.

2EU & UK Regulatory Framework

In the European Union (EU) and the United Kingdom (UK), ephedrine is classified as a controlled substance due to its potential for misuse. The European Medicines Agency (EMA) and the UK's Medicines and Healthcare products Regulatory Agency (MHRA) mandate that products containing ephedrine undergo rigorous evaluation to obtain marketing authorization. Compliance with Good Manufacturing Practice (GMP) standards is essential, ensuring that products meet the required quality, safety, and efficacy standards.

Indian exporters targeting these markets must ensure that their manufacturing processes align with EU and UK GMP requirements. This includes regular inspections and audits to verify compliance, thereby facilitating the approval process and market entry.

3WHO Essential Medicines & Global Standards

As of the 24th edition of the WHO Model List of Essential Medicines, updated in September 2025, ephedrine is not included. The WHO Model List serves as a guide for countries to develop their national essential medicines lists, focusing on medicines that address priority health needs. (who.int)

Despite its exclusion from the WHO Model List, ephedrine must comply with international pharmacopoeia standards, including those set by the United States Pharmacopeia (USP), British Pharmacopoeia (BP), European Pharmacopoeia (EP), and Indian Pharmacopoeia (IP). Adherence to these standards ensures the quality and safety of ephedrine products in the global market.

4India Regulatory Classification

In India, ephedrine is classified as a Schedule X drug under the Drugs and Cosmetics Act, indicating its high potential for abuse and stringent regulatory controls. The National Pharmaceutical Pricing Authority (NPPA) sets ceiling prices for essential medicines; however, as of March 2026, ephedrine is not listed under the Drugs (Prices Control) Order (DPCO), and thus, no ceiling price has been established.

For export purposes, the Directorate General of Foreign Trade (DGFT) requires a No Objection Certificate (NOC) for the export of controlled substances like ephedrine. This ensures that exports comply with national regulations and international commitments to prevent misuse.

5Patent & Exclusivity Status

Ephedrine is a well-established pharmaceutical compound with no active patents or exclusivity rights, allowing for generic production and export. This has led to a competitive market with multiple manufacturers and exporters, as evidenced by the 59 active Indian exporters between 2022 and 2026.

6Recent Industry Developments

In January 2025, the FDA updated Import Alert 54-13 to reinforce the detention without physical examination of dietary supplements and bulk dietary ingredients containing ephedrine alkaloids from all countries. This action underscores the FDA's ongoing efforts to prevent the entry of potentially harmful substances into the U.S. market.

In May 2025, the WHO Expert Committee on Selection and Use of Essential Medicines convened to update the WHO Model List of Essential Medicines. The 24th edition, published in September 2025, did not include ephedrine, reflecting its current status in global health priorities. (who.int)

In February 2026, the NPPA conducted a review of the Drugs (Prices Control) Order (DPCO) list. Ephedrine was not added to the list, indicating that no ceiling price has been established for this compound as of March 2026.

These developments highlight the dynamic regulatory environment surrounding ephedrine, emphasizing the need for exporters to stay informed and compliant with international standards and regulations.

TransData Nexus Research · FDA Orange Book, EMA, WHO Model List, CDSCO/NPPAUpdated Mar 2026

Get Complete Export Intelligence Report

300+ pages · Supplier profiles · Buyer analysis · Price benchmarks · Every shipment record

Free

Global Price Benchmark — Ephedrine

Retail & reference prices across 9 markets vs. India FOB export price of $11.28/unit

Global Price Benchmark for Ephedrine across major pharmaceutical markets
Market	Price (USD/unit)	Currency	Reference
United States	N/A	USD	Ephedrine is regulated by the U.S. Food and Drug Administration (FDA). However, specific pricing information for the 500 mg tablet formulation is not readily available in public FDA resources.
United Kingdom	N/A	GBP	The Medicines and Healthcare products Regulatory Agency (MHRA) oversees the regulation of Ephedrine in the UK. Specific pricing data for the 500 mg tablet formulation is not publicly accessible.
Germany	N/A	EUR	The Federal Institute for Drugs and Medical Devices (BfArM) regulates Ephedrine in Germany. Publicly available pricing information for the 500 mg tablet formulation is not found.

Supply Chain Risk Assessment — Ephedrine

API sourcing, concentration risk, storage requirements, and current alerts

HIGH RISK

1API Sourcing & Raw Material Dependency

India's pharmaceutical industry, including the production of ephedrine, heavily relies on imports of Key Starting Materials (KSMs) and intermediates from China. China controls approximately 70–80% of the global KSM supply and 60–70% of intermediates, making it a dominant player in the API sector. This dependency exposes Indian manufacturers to supply chain vulnerabilities, as any disruptions in Chinese exports can significantly impact production timelines and costs.

Recent geopolitical tensions have further exacerbated these risks. In June 2025, escalating conflicts in the Middle East led to the closure of the Strait of Hormuz, a critical chokepoint for global energy and chemical shipments. This disruption affected the availability of petrochemical feedstocks essential for API synthesis, leading to increased production costs and potential delays in pharmaceutical manufacturing. (pharmasource.global)

2Supplier Concentration & Single-Source Risk

Our proprietary trade data indicates that the top five Indian exporters of ephedrine account for 67.8% of total exports, with MANKIND PHARMA LIMITED alone contributing 20.2%. This high supplier concentration poses a significant risk, as any operational or compliance issues within these key companies could disrupt the global supply chain.

To mitigate such risks, the Indian government introduced the Production Linked Incentive (PLI) scheme aimed at boosting domestic API manufacturing and reducing reliance on imports. The scheme has led to increased investments in local production capacities, enhancing supply chain resilience. (pharmanow.live)

Access Complete Ephedrine Trade Intelligence

Shipment-level records, verified supplier contacts, buyer histories, and pricing analytics for all 389 transactions across 56 markets.

Request Demo View Pricing

Frequently Asked Questions — Ephedrine Exports from India

Data-backed answers sourced from Indian Customs shipping bill records

Who are the top ephedrine exporters from India?

The leading ephedrine exporters from India are MANKIND PHARMA LIMITED, SUN PHARMACEUTICAL INDUSTRIES LIMITED, LABORATE PHARMACEUTICALS INDIA LTD, and 10 others. MANKIND PHARMA LIMITED leads with 20.2% market share ($4.6M). The top 5 suppliers together control 67.8% of total export value.

What is the total export value of ephedrine from India?

The total export value of ephedrine from India is $22.5M, recorded across 389 shipments from 59 active exporters to 56 countries. The average shipment value is $57.9K.

Which countries import ephedrine from India?

India exports ephedrine to 56 countries. The top importing countries are UNITED STATES (60.5%), NIGERIA (20.6%), CANADA (9.8%), KENYA (1.2%), ALGERIA (1.0%), which together account for 93.1% of total export value.

What is the HS code for ephedrine exports from India?

The primary HS code for ephedrine exports from India is 30049099. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) to track and report pharmaceutical export flows.

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Ephedrine

Ephedrine

How India Exports Ephedrine to the World

Top Ephedrine Exporters from India

Top Countries Importing Ephedrine from India

Quick Facts

Related Respiratory & OTC

Related Analysis

Need Details?

Regulatory Landscape — Ephedrine

1FDA & US Market Regulatory Status

2EU & UK Regulatory Framework

3WHO Essential Medicines & Global Standards

4India Regulatory Classification

5Patent & Exclusivity Status

6Recent Industry Developments

Global Price Benchmark — Ephedrine

Supply Chain Risk Assessment — Ephedrine

1API Sourcing & Raw Material Dependency

2Supplier Concentration & Single-Source Risk

Access Complete Ephedrine Trade Intelligence

Frequently Asked Questions — Ephedrine Exports from India

Who are the top ephedrine exporters from India?

What is the total export value of ephedrine from India?

Which countries import ephedrine from India?

What is the HS code for ephedrine exports from India?

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

India Cost Advantage

3Geopolitical & Shipping Disruptions

4Risk Mitigation Recommendations

What is the average price of ephedrine exports from India?

Which ports handle ephedrine exports from India?

Why is India a leading exporter of ephedrine?

What certifications do Indian ephedrine exporters need?

How many buyers import ephedrine from India?

What is the market share of the top ephedrine exporter from India?

Analysis Methodology